Patents Represented by Attorney Julie M. Blackburn
  • Patent number: 8344024
    Abstract: An anhydrous color cosmetic composition comprising at least one resveratrol derivative and particulates; and an anhydrous emulsion skin care composition.
    Type: Grant
    Filed: May 27, 2008
    Date of Patent: January 1, 2013
    Assignee: ELC Management LLC
    Inventors: Anna Czarnota, Lisa Qu, Fatemeh Mohammadi, Julius R. Zecchino
  • Patent number: 8080583
    Abstract: An emulsion cosmetic composition comprising at least one resveratrol derivative, a water phase, and an oil phase containing at least one linear or branched volatile or near volatile silicone and a method for delivering active resveratrol to the skin.
    Type: Grant
    Filed: May 27, 2008
    Date of Patent: December 20, 2011
    Assignee: ELC Management LLC
    Inventors: Daniel H. Maes, Fatemeh Mohammadi, Lisa Qu, Anna Czarnota, Thomas Mammone, Lieve Declercq, Julius R. Zecchino
  • Patent number: 7749284
    Abstract: Oxidative hair dye compositions containing at least one antioxidant botanical extract operable to inhibit the oxidative degradation of one or more oxidative dyes present in the oxidative dye composition, methods for coloring hair, and methods and products that enable multiple use oxidative dye containers.
    Type: Grant
    Filed: April 28, 2008
    Date of Patent: July 6, 2010
    Assignee: Aveda Corporation
    Inventors: Jennifer Lockridge, Cindy L. Orr, Darcy Lyn Prater, Vilis Zaeska
  • Patent number: 4904823
    Abstract: There is described a process for the manufacture of hydroquinone derivatives of the formulae ##STR1## which are valuable intermediates in the synthesis of natural vitamin E.
    Type: Grant
    Filed: January 23, 1989
    Date of Patent: February 27, 1990
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Richard Barner, Josef Hubscher
  • Patent number: 4900478
    Abstract: The novel compounds of the formulaRet-OA IwhereinRet is the acyl residue of a retinoid carboxylic acid, A is a residue (--CHR)--CH.sub.2 O).sub.n R.sup.1, (--CH.sub.2).sub.m SR.sup.1, (--CH.sub.2).sub.m XR.sup.2, (--CH.sub.2).sub.m --Het, --N(R.sup.2).sub.2, --C(R.sup.4).sub.2 OC(O)R.sup.3, --CH.sub.2 --CH(OR.sup.2)CH.sub.2 OR.sup.2 or --CH(CH.sub.2 OR.sup.2).sub.2 ;R is hydrogen or methyl,R.sup.1 is hydrogen, C.sub.1-6 -alkyl or C.sub.1-6 -alkanoyl,R.sup.2 is C.sub.1-6 -alkyl,R.sup.3 is C.sub.1-6 -alkyl, C.sub.1-6 -alkoxy, di-C.sub.1-6 -alkylamino, phenyl, substituted phenyl, styryl or styryl or 2-benzoyl-phenoxy-C.sub.1-6 -alkyl substituted in the phenyl residue;R.sup.4 is hydrogen, C.sub.1-6 -alkyl or phenyl;X is >SO or >SO.sub.2,Het is the residue of a N-heterocyclic ring,n is a whole number of 3-40 andm is a whole number of 1-4, with the proviso that R.sup.1 is C.sub.1-6 -alkyl or C.sub.1-6 -alkanoyl when A is a --CH.sub.2 SR.sup.
    Type: Grant
    Filed: September 30, 1987
    Date of Patent: February 13, 1990
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Gunter Gross